Healthcare provider profile · identity verified

Tracy L Laidley, MD

Internal Medicine · PORTLAND, OR · NPI 1437128451

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	283	67
Atorvastatin Calcium	Atorvastatin Calcium	234	65
Lisinopril	Lisinopril	144	40
Amlodipine Besylate	Amlodipine Besylate	130	36
Losartan Potassium	Losartan Potassium	123	35
Omeprazole	Omeprazole	104	28
Metoprolol Succinate	Metoprolol Succinate	95	23
Bupropion Xl	Bupropion Hcl	88	28
Gabapentin	Gabapentin	83	30
Simvastatin	Simvastatin	69	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	67	19
Sertraline Hcl	Sertraline Hcl	60	13
Metformin Hcl Er	Metformin Hcl	58	17
Rosuvastatin Calcium	Rosuvastatin Calcium	58	19
Trazodone Hcl	Trazodone Hcl	58	19
Alendronate Sodium	Alendronate Sodium	57	17
Duloxetine Hcl	Duloxetine Hcl	55	15
Metformin Hcl	Metformin Hcl	53	14
Furosemide	Furosemide	52	17
Zolpidem Tartrate	Zolpidem Tartrate	51	19
Tamsulosin Hcl	Tamsulosin Hcl	47	suppressed
Oxycodone Hcl	Oxycodone Hcl	46	16
Estradiol	Estradiol	42	21
Metoprolol Tartrate	Metoprolol Tartrate	42	12
Hydrochlorothiazide	Hydrochlorothiazide	40	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	39	23
Alprazolam	Alprazolam	39	13
Atenolol	Atenolol	37	11
Synthroid	Levothyroxine Sodium	36	12
Escitalopram Oxalate	Escitalopram Oxalate	33	11
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Lovastatin	Lovastatin	32	suppressed
Spironolactone	Spironolactone	32	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	29	suppressed
Celecoxib	Celecoxib	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Carvedilol	Carvedilol	26	suppressed
Potassium Chloride	Potassium Chloride	26	suppressed
Allopurinol	Allopurinol	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Montelukast Sodium	Montelukast Sodium	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Tramadol Hcl	Tramadol Hcl	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	14
Eliquis	Apixaban	23	suppressed
Prednisone	Prednisone	23	14
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Doxepin Hcl	Doxepin Hcl	21	suppressed
Lorazepam	Lorazepam	21	12
Pregabalin	Pregabalin	21	suppressed
Progesterone	Progesterone, Micronized	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Estradiol (Once Weekly)	Estradiol	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Valsartan	Valsartan	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Finasteride	Finasteride	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Ozempic	Semaglutide	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Primidone	Primidone	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Clopidogrel	Clopidogrel Bisulfate	11	suppressed
Diazepam	Diazepam	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error